Skip to main content

REDES GENICAS REGULADORAS EN CELULAS DE CANCER DE MAMA EXPUESTAS A PROGESTINICOS

SAF2016-75006-P

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACIO CENTRE DE REGULACIO GENOMICA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 24
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

LATS1 controls CTCF chromatin occupancy and hormonal response of 3D-grown breast cancer cells

  • Ramírez Cuéllar, Angélica Julieta
  • Ferrari, Roberto
  • Sanz, Rosario T.
  • Valverde Santiago, Marta
  • García García, Judith
  • Nacht, A. Silvina
  • Castillo, David
  • Le Dily, François
  • Neguembor, Maria Victoria
  • Malatesta, Marco
  • Bonnin, Sarah
  • Martí Renom, Marc A.
  • Beato, Miguel
  • Vicent, Guillermo P.
The cancer epigenome has been studied in cells cultured in two-dimensional (2D) monolayers, but recent studies highlight the impact of the extracellular matrix and the three-dimensional (3D) environment on multiple cellular functions. Here, we report the physical, biochemical, and genomic differences between T47D breast cancer cells cultured in 2D and as 3D spheroids. Cells within 3D spheroids exhibit a rounder nucleus with less accessible, more compacted chromatin, as well as altered expression of ~2000 genes, the majority of which become repressed. Hi-C analysis reveals that cells in 3D are enriched for regions belonging to the B compartment, have decreased chromatin-bound CTCF and increased fusion of topologically associating domains (TADs). Upregulation of the Hippo pathway in 3D spheroids results in the activation of the LATS1 kinase, which promotes phosphorylation and displacement of CTCF from DNA, thereby likely causing the observed TAD fusions. 3D cells show higher chromatin binding of progesterone receptor (PR), leading to an increase in the number of hormone-regulated genes. This effect is in part mediated by LATS1 activation, which favors cytoplasmic retention of YAP and CTCF removal., The authors would like to thank Jianrong Lu (University of Florida College of Medicine, USA) for generously sharing the CTCF constructs. Additionally, we also would like to thank Dr. Julia Ponomarenko (Bioinformatics Unit, CRG) for their valuable advice, technical assistance and involvement in processing the RNA-seq, ChIP-seq, and ATAC-seq data. The experimental work was supported by grants from the Departament d’Innovació Universitat i Empresa (DIUiE), the Spanish Ministry of Economy and Competitiveness (SAF2016-75006-P, PID2019-105173RB-I00, and PID2022-137045OB-I00) and Consejo Superior de Investigaciones Científicas (Ref# 201820I131), ‘Centro de Excelencia Severo Ochoa 2013-2017’, SEV-2012-2018 and ERC Synergy Grant “4DGenome” nr: 609989. MAM-R acknowledges support by the Spanish Ministerio de Ciencia e Innovación (PID2020-115696RB-I00). This work has benefited from the equipment and framework of the COMP-HUB and COMP-R Initiatives, funded by the ‘Departments of Excellence’ program of the Italian Ministry for University and Research (MIUR, 2018-2022 and MUR, 2023-2027) and from the HPC (High-Performance Computing) facility of the University of Parma, Italy.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Hormone-control regions mediate steroid receptor-dependent genome organization

  • Le Dily, François
  • Vidal, Enrique
  • Cuartero, Yasmina
  • Quilez Oliete, Javier
  • Nacht, A. Silvina
  • Vicent, Guillermo P.
  • Carbonell-Caballero, Jose
  • Sharma, Priyanka
  • Villanueva Cañas, José Luis, 1984-
  • Ferrari, Roberto
  • De Llobet, Lara Isabel
  • Verde, Gaetano
  • Wright, Roni H.G.
  • Beato, Miguel
In breast cancer cells, some topologically associating domains (TADs) behave as hormonal gene regulation units, within which gene transcription is coordinately regulated in response to steroid hormones. Here we further describe that responsive TADs contain 20- to 100-kb-long clusters of intermingled estrogen receptor (ESR1) and progesterone receptor (PGR) binding sites, hereafter called hormone-control regions (HCRs). In T47D cells, we identified more than 200 HCRs, which are frequently bound by unliganded ESR1 and PGR. These HCRs establish steady long-distance inter-TAD interactions between them and organize characteristic looping structures with promoters in their TADs even in the absence of hormones in ESR1+-PGR+ cells. This organization is dependent on the expression of the receptors and is further dynamically modulated in response to steroid hormones. HCRs function as platforms that integrate different signals, resulting in some cases in opposite transcriptional responses to estrogens or progestins. Altogether, these results suggest that steroid hormone receptors act not only as hormone-regulated sequence-specific transcription factors but also as local and global genome organizers., We received funding from the European Research Council under the European Union's Seventh Framework Program (FP7/2007–2013)/ERC Synergy grant agreement 609989 (4DGenome). The content of this manuscript reflects only the author's views and the Union is not liable for any use that may be made of the information contained therein. We acknowledge support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013–2017’ and Plan Nacional (SAF2016-75006-P), as well as support of the CERCA Programme/Generalitat de Catalunya.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

MyoD induces ARTD1 and nucleoplasmic poly-ADP-ribosylation during fibroblast to myoblast transdifferentiation

  • Bisceglie, Lavinia
  • Hopp, Ann-Katrin
  • Gunasekera, Kapila
  • Wright, Roni H.G.
  • Le Dily, François
  • Vidal, Enrique
  • Dall'Agnese, Alessandra
  • Caputo, Luca
  • Nicoletti, Chiara
  • Puri, Pier Lorenzo
  • Beato, Miguel
  • Hottiger, Michael O.
While protein ADP-ribosylation was reported to regulate differentiation and dedifferentiation, it has so far not been studied during transdifferentiation. Here, we found that MyoD-induced transdifferentiation of fibroblasts to myoblasts promotes the expression of the ADP-ribosyltransferase ARTD1. Comprehensive analysis of the genome architecture by Hi-C and RNA-seq analysis during transdifferentiation indicated that ARTD1 locally contributed to A/B compartmentalization and coregulated a subset of MyoD target genes that were however not sufficient to alter transdifferentiation. Surprisingly, the expression of ARTD1 was accompanied by the continuous synthesis of nuclear ADP ribosylation that was neither dependent on the cell cycle nor induced by DNA damage. Conversely to the H2O2-induced ADP-ribosylation, the MyoD-dependent ADP-ribosylation was not associated to chromatin but rather localized to the nucleoplasm. Together, these data describe a MyoD-induced nucleoplasmic ADP-ribosylation that is observed particularly during transdifferentiation and thus potentially expands the plethora of cellular processes associated with ADP-ribosylation., Research in Beato's lab is supported by funds from the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC Synergy grant agreement 609989 (4DGenome), from the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013-2017’ and Plan Nacional (SAF2016-75006-P), as well as support of the CERCA Program/Generalitat de Catalunya. L.B was supported by the Forschungskredit 2019 of the University of Zurich and K.G by a grant of the Oncosuisse (Nr. KFS-3740-08-2015-R). ADP-ribosylation research in the laboratory of MOH is funded by the Kanton of Zurich and the Swiss National Science Foundation, Switzerland (grant 31003A_176177).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The embryonic linker histone dBigH1 alters the functional state of active chromatin

  • Climent-Cantó, Paula
  • Carbonell, Albert
  • Tatarski, Milos
  • Reina García, Óscar, 1976-
  • Bujosa, Paula
  • Font Mateu, Jofre, 1977-
  • Bernués, Jordi
  • Beato, Miguel
  • Azorín Marín, Fernando
Linker histones H1 are principal chromatin components, whose contribution to the epigenetic regulation of chromatin structure and function is not fully understood. In metazoa, specific linker histones are expressed in the germline, with female-specific H1s being normally retained in the early-embryo. Embryonic H1s are present while the zygotic genome is transcriptionally silent and they are replaced by somatic variants upon activation, suggesting a contribution to transcriptional silencing. Here we directly address this question by ectopically expressing dBigH1 in Drosophila S2 cells, which lack dBigH1. We show that dBigH1 binds across chromatin, replaces somatic dH1 and reduces nucleosome repeat length (NRL). Concomitantly, dBigH1 expression down-regulates gene expression by impairing RNApol II binding and histone acetylation. These effects depend on the acidic N-terminal ED-domain of dBigH1 since a truncated form lacking this domain binds across chromatin and replaces dH1 like full-length dBigH1, but it does not affect NRL either transcription. In vitro reconstitution experiments using Drosophila preblastodermic embryo extracts corroborate these results. Altogether these results suggest that the negatively charged N-terminal tail of dBigH1 alters the functional state of active chromatin compromising transcription., Funding: MINECO [BFU2015-65082-P, PGC2018-094538-B-100]; Generalitat de Catalunya [SGR2014-204, SGR2017-475]; European Community FEDER program (to F.A.); MEC ‘Centro de Excelencia Severo Ochoa 2013–2017’ [SEV-2012-0208]; MINECO [SAF2016-75006-P to M.B.]; ‘Centre de Referència en Biotecnologia’ of the Generalitat de Catalunya. Funding for open access charge: MINECO
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations

  • Zaurín Quer, Roser
  • Ferrari, Roberto
  • Nacht, A. Silvina
  • Carbonell-Caballero, Jose
  • Le Dily, François
  • Font Mateu, Jofre, 1977-
  • De Llobet, Lara Isabel
  • Vidal Ocabo, Enrique
  • Lioutas, Antonio, 1980-
  • Beato, Miguel
  • Vincent, Guillermo P.
Here, we report that in T47D breast cancer cells 50 pM progestin is sufficient to activate cell cycle entry and the progesterone gene expression program. At this concentration, equivalent to the progesterone blood levels found around the menopause, progesterone receptor (PR) binds only to 2800 genomic sites, which are accessible to ATAC cleavage prior to hormone exposure. These highly accessible sites (HAs) are surrounded by well-organized nucleosomes and exhibit breast enhancer features, including estrogen receptor alpha (ERα), higher FOXA1 and BRD4 (bromodomain containing 4) occupancy. Although HAs are enriched in RAD21 and CTCF, PR binding is the driving force for the most robust interactions with hormone-regulated genes. HAs show higher frequency of 3D contacts among themselves than with other PR binding sites, indicating colocalization in similar compartments. Gene regulation via HAs is independent of classical coregulators and ATP-activated remodelers, relying mainly on MAP kinase activation that enables PR nuclear engagement. HAs are also preferentially occupied by PR and ERα in breast cancer xenografts derived from MCF-7 cells as well as from patients, indicating their potential usefulness as targets for therapeutic intervention., Funding: Ministerio de Ciencia e Innovación [PID2019-105173RB-I00 and PID2019-110384GB-C21]; Spanish Ministry of Economy and Competitiveness [SAF2016-75006-P and G62426937]; Consejo Superior de Investigaciones Científicas [201820I131]; Centro de Excelencia Severo Ochoa [SEV-2012-2018]; European Research Council [609989]. Funding for open access charge: Ministerio de Ciencia e Innovación
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells

  • Ogara, Maria F.
  • Rodríguez Seguí, Santiago A.
  • Marini, Melisa
  • Silvina Nacht, Ana
  • Stortz, Martin
  • Levi, Valeria
  • Presman, Diego M.
  • Vicent, Guillermo P.
  • Pecci, Adali
The glucocorticoid and progesterone receptors (GR and PR) are closely related members of the steroid receptor family. Despite sharing similar structural and functional characteristics; the cognate hormones display very distinct physiological responses. In mammary epithelial cells, PR activation is associated with the incidence and progression of breast cancer, whereas the GR is related to growth suppression and differentiation. Despite their pharmacological relevance, only a few studies have compared GR and PR activities in the same system. Using a PR+/GR+ breast cancer cell line, here we report that either glucocorticoid-free or dexamethasone (DEX)-activated GR inhibits progestin-dependent gene expression associated to epithelial-mesenchymal-transition and cell proliferation. When both receptors are activated with their cognate hormones, PR and GR can form part of the same complex according to co-immunoprecipitation, quantitative microscopy and sequential ChIP experiments. Moreover, genome-wide studies in cells treated with either DEX or R5020, revealed the presence of several regions co-bound by both receptors. Surprisingly, GR also binds novel genomic sites in cells treated with R5020 alone. This progestin-induced GR binding was enriched in REL DNA motifs and located close to genes coding for chromatin remodelers. Understanding GR behavior in the context of progestin-dependent breast cancer could provide new targets for tumor therapy., Spanish Ministry of Economy and Competitiveness, Spain [SAF2016-75006P]; CONICET [PIP112-200801-00859]; Agencia Nacional de Programación Científica y Tecnológica [Préstamo BID-PICT2014-0630]; University of Buenos Aires, Argentina [20820180100745BA]. CONICET-Argentina (M.F.O., S.A.R.S., V.L, D.M.P, A.P.); Spanish National Research Council (CSIC), Spain (to G.P.V.); IUBMB Short-term Scholarship (to M.F.O, M.S.M.); EMBO Short-term Scholarship (to M.F.O.).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells

  • Nacht, A. Silvina
  • Ferrari, Roberto
  • Zaurín Quer, Roser
  • Scabia, Valentina
  • Carbonell-Caballero, Jose
  • Le Dily, François
  • Quilez Oliete, Javier
  • Leopoldi, Alexandra
  • Brisken, Cathrin
  • Beato, Miguel
  • Vicent, Guillermo P.
Steroid hormones are key gene regulators in breast cancer cells. While estrogens stimulate cell proliferation, progestins activate a single cell cycle followed by proliferation arrest. Here, we use biochemical and genome-wide approaches to show that progestins achieve this effect via a functional crosstalk with C/EBPα. Using ChIP-seq, we identify around 1,000 sites where C/EBPα binding precedes and helps binding of progesterone receptor (PR) in response to hormone. These regions exhibit epigenetic marks of active enhancers, and C/EBPα maintains an open chromatin conformation that facilitates loading of ligand-activated PR. Prior to hormone exposure, C/EBPα favors promoter-enhancer contacts that assure hormonal regulation of key genes involved in cell proliferation by facilitating binding of RAD21, YY1, and the Mediator complex. Knockdown of C/EBPα disrupts enhancer-promoter contacts and decreases the presence of these architectural proteins, highlighting its key role in 3D chromatin looping. Thus, C/EBPα fulfills a previously unknown function as a potential growth modulator in hormone-dependent breast cancer., The experimental work was supported by grants from the Departament d’Innovació, Universitat i Empresa (DIUiE), and the Spanish Ministry of Economy and Competitiveness (SAF2016-75006P), “Centro de Excelencia Severo Ochoa 2013-2017”, SEV-2012-0208 and ERC Synergy Grant “4DGenome” nr: 609989
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Signaling by steroid hormones in the 3D nuclear space

  • Le Dily, François
  • Beato, Miguel
Initial studies showed that ligand-activated hormone receptors act by binding to the proximal promoters of individual target genes. Genome-wide studies have now revealed that regulation of transcription by steroid hormones mainly depends on binding of the receptors to distal regulatory elements. Those distal elements, either enhancers or silencers, act on the regulation of target genes by chromatin looping to the gene promoters. In the nucleus, this level of chromatin folding is integrated within dynamic higher orders of genome structures, which are organized in a non-random fashion. Terminally differentiated cells exhibit a tissue-specific three-dimensional (3D) organization of the genome that favors or restrains the activity of transcription factors and modulates the function of steroid hormone receptors, which are transiently activated upon hormone exposure. Conversely, integration of the hormones signal may require modifications of the 3D organization to allow appropriate transcriptional outcomes. In this review, we summarize the main levels of organization of the genome, review how they can modulate the response to steroids in a cell specific manner and discuss the role of receptors in shaping and rewiring the structure in response to hormone. Taking into account the dynamics of 3D genome organization will contribute to a better understanding of the pleiotropic effects of steroid hormones in normal and cancer cells., We thank all members of the Chromatin and Gene Expression group (CRG, Barcelona) and the members of the 4DGenome project (CRG and CNAG-CRG, Barcelona) for helpful discussions. Research in the Beato’s laboratory receives funding from the European Research Council under the European Union’s Seventh Framework Programme (FP7/2007-2013)/ERC Synergy grant agreement 609989 (4DGenome). The content of this manuscript reflects only the author’s views and the Union is not liable for any use that may be made of the information contained therein. We also acknowledge support of the Spanish Ministry of Economy and Competitiveness, “Centro de Excelencia Severo Ochoa 2013-2017” and Plan Nacional (SAF2016-75006-P), as well as support of the CERCA Programme/Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells

  • Nacht, Ana Silvina
  • Ferrari, Roberto
  • Zaurin, Roser
  • Scabia, Valentina
  • Carbonell‐Caballero, José
  • Le Dily, Francois
  • Quilez, Javier
  • Leopoldi, Alexandra
  • Brisken, Cathrin
  • Beato, Miguel
  • Vicent, Guillermo P.
Steroid hormones are key gene regulators in breast cancer cells. While estrogens stimulate cell proliferation, progestins activate a single cell cycle followed by proliferation arrest. Here, we use biochemical and genome‐wide approaches to show that progestins achieve this effect via a functional crosstalk with C/EBPα. Using ChIP‐seq, we identify around 1,000 sites where C/EBPα binding precedes and helps binding of progesterone receptor (PR) in response to hormone. These regions exhibit epigenetic marks of active enhancers, and C/EBPα maintains an open chromatin conformation that facilitates loading of ligand‐activated PR. Prior to hormone exposure, C/EBPα favors promoter–enhancer contacts that assure hormonal regulation of key genes involved in cell proliferation by facilitating binding of RAD21, YY1, and the Mediator complex. Knockdown of C/EBPα disrupts enhancer–promoter contacts and decreases the presence of these architectural proteins, highlighting its key role in 3D chromatin looping. Thus, C/EBPα fulfills a previously unknown function as a potential growth modulator in hormone‐dependent breast cancer., The experimental work was supported by grants from the Departament d'Innovació Universitat i Empresa (DIUiE), and the Spanish Ministry of Economy and Competitiveness (SAF2016‐75006P), “Centro de Excelencia Severo Ochoa 2013‐2017”, SEV‐2012‐0208 and ERC Synergy Grant “4DGenome” nr: 609989.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells

  • Ogara, Maria F.
  • Rodríguez-Seguí, Santiago A.
  • Marini, Melisa
  • Nacht, Ana Silvina
  • Stortz, Martin
  • Levi, Valeria
  • Presman, Diego M.
  • Vicent, Guillermo P.
  • Pecci, Adali
The glucocorticoid and progesterone receptors (GR and PR) are closely related members of the steroid receptor family. Despite sharing similar structural and functional characteristics; the cognate hormones display very distinct physiological responses. In mammary epithelial cells, PR activation is associated with the incidence and progression of breast cancer, whereas the GR is related to growth suppression and differentiation. Despite their pharmacological relevance, only a few studies have compared GR and PR activities in the same system. Using a PR+/GR+ breast cancer cell line, here we report that either glucocorticoid-free or dexamethasone (DEX)-activated GR inhibits progestin-dependent gene expression associated to epithelial-mesenchymal-transition and cell proliferation. When both receptors are activated with their cognate hormones, PR and GR can form part of the same complex according to co-immunoprecipitation, quantitative microscopy and sequential ChIP experiments. Moreover, genome-wide studies in cells treated with either DEX or R5020, revealed the presence of several regions co-bound by both receptors. Surprisingly, GR also binds novel genomic sites in cells treated with R5020 alone. This progestin-induced GR binding was enriched in REL DNA motifs and located close to genes coding for chromatin remodelers. Understanding GR behavior in the context of progestin-dependent breast cancer could provide new targets for tumor therapy., Spanish Ministry of Economy and Competitiveness, Spain [SAF2016-75006P]; CONICET [PIP112-200801-00859]; Agencia Nacional de Programación Científica y Tecnológica [Préstamo BID-PICT2014-0630]; University of Buenos Aires, Argentina [20820180100745BA]. CONICET-Argentina (M.F.O., S.A.R.S., V.L, D.M.P, A.P.); Spanish National Research Council (CSIC), Spain (to G.P.V.); IUBMB Short-term Scholarship (to M.F.O, M.S.M.); EMBO Short-term Scholarship (to M.F.O.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Hormone-control regions mediate steroid receptor–dependent genome organization

  • Le Dily, Francois
  • Vidal, Enrique
  • Cuartero, Yasmina
  • Quilez, Javier
  • Nacht, A. Silvina
  • Vicent, Guillermo P.
  • Carbonell-Caballero, José
  • Sharma, Priyanka
  • Villanueva-Cañas, José Luis
  • Ferrari, Roberto
  • Llobet, Lara Isabel de
  • Verde, Gaetano
  • Wright, Roni H. G.
  • Beato, Miguel
In breast cancer cells, some topologically associating domains (TADs) behave as hormonal gene regulation units, within which gene transcription is coordinately regulated in response to steroid hormones. Here we further describe that responsive TADs contain 20- to 100-kb-long clusters of intermingled estrogen receptor (ESR1) and progesterone receptor (PGR) binding sites, hereafter called hormone-control regions (HCRs). In T47D cells, we identified more than 200 HCRs, which are frequently bound by unliganded ESR1 and PGR. These HCRs establish steady long-distance inter-TAD interactions between them and organize characteristic looping structures with promoters in their TADs even in the absence of hormones in ESR1-PGR cells. This organization is dependent on the expression of the receptors and is further dynamically modulated in response to steroid hormones. HCRs function as platforms that integrate different signals, resulting in some cases in opposite transcriptional responses to estrogens or progestins. Altogether, these results suggest that steroid hormone receptors act not only as hormone-regulated sequence-specific transcription factors but also as local and global genome organizers., Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013–2017’ and Plan Nacional (SAF2016-75006-P), as well as support of the CERCA Programme/ Generalitat de Catalunya
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The embryonic linker histone dBigH1 alters the functional state of active chromatin

  • Climent-Cantó, Paula
  • Carbonell, Albert
  • Tatarski, Milos
  • Reina, Oscar
  • Bujosa, Paula
  • Font-Mateu, Jofre
  • Bernués, Jordi
  • Beato, Miguel
  • Azorin, Fernando
© The Author(s) 2020., Linker histones H1 are principal chromatin components, whose contribution to the epigenetic regulation of chromatin structure and function is not fully understood. In metazoa, specific linker histones are expressed in the germline, with female-specific H1s being normally retained in the early-embryo. Embryonic H1s are present while the zygotic genome is transcriptionally silent and they are replaced by somatic variants upon activation, suggesting a contribution to transcriptional silencing. Here we directly address this question by ectopically expressing dBigH1 in Drosophila S2 cells, which lack dBigH1. We show that dBigH1 binds across chromatin, replaces somatic dH1 and reduces nucleosome repeat length (NRL). Concomitantly, dBigH1 expression down-regulates gene expression by impairing RNApol II binding and histone acetylation. These effects depend on the acidic N-terminal ED-domain of dBigH1 since a truncated form lacking this domain binds across chromatin and replaces dH1 like full-length dBigH1, but it does not affect NRL either transcription. In vitro reconstitution experiments using Drosophila preblastodermic embryo extracts corroborate these results. Altogether these results suggest that the negatively charged N-terminal tail of dBigH1 alters the functional state of active chromatin compromising transcription., MINECO [BFU2015-65082-P, PGC2018-094538-B-100]; Generalitat de Catalunya [SGR2014-204, SGR2017-475]; European Community FEDER program (to F.A.); MEC ‘Centro de Excelencia Severo Ochoa 2013–2017’ [SEV-2012-0208]; MINECO [SAF2016-75006-P to M.B.]; ‘Centre de Referència en Biotecnologia’ of the Generalitat de Catalunya. Funding for open access charge: MINECO.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations

  • Zaurin, Roser
  • Ferrari, Roberto
  • Carbonell‐Caballero, José
  • Le Dily, Francois
  • Font-Mateu, Jofre
  • Llobet Cucalon, Lara Isabel de
  • Vidal, Enrique
  • Lioutas, Antonios
  • Beato, Miguel
  • Vicent, Guillermo P.
© The Author(s) 2021., Here, we report that in T47D breast cancer cells 50 pM progestin is sufficient to activate cell cycle entry and the progesterone gene expression program. At this concentration, equivalent to the progesterone blood levels found around the menopause, progesterone receptor (PR) binds only to 2800 genomic sites, which are accessible to ATAC cleavage prior to hormone exposure. These highly accessible sites (HAs) are surrounded by well-organized nucleosomes and exhibit breast enhancer features, including estrogen receptor alpha (ERα), higher FOXA1 and BRD4 (bromodomain containing 4) occupancy. Although HAs are enriched in RAD21 and CTCF, PR binding is the driving force for the most robust interactions with hormone-regulated genes. HAs show higher frequency of 3D contacts among themselves than with other PR binding sites, indicating colocalization in similar compartments. Gene regulation via HAs is independent of classical coregulators and ATP-activated remodelers, relying mainly on MAP kinase activation that enables PR nuclear engagement. HAs are also preferentially occupied by PR and ERα in breast cancer xenografts derived from MCF-7 cells as well as from patients, indicating their potential usefulness as targets for therapeutic intervention., Ministerio de Ciencia e Innovación [PID2019-105173RB-I00 and PID2019-110384GB-C21]; Spanish Ministry of Economy and Competitiveness [SAF2016-75006-P and G62426937]; Consejo Superior de Investigaciones Científicas [201820I131]; Centro de Excelencia Severo Ochoa [SEV-2012-2018]; European Research Council [609989]. Funding for open access charge: Ministerio de Ciencia e Innovación.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

LATS1 controls CTCF chromatin occupancy and hormonal response of 3D-grown breast cancer cells

  • Ramirez-Cuellar, A. Julieta
  • Ferrari, Roberto
  • Sanz, Rosario T.
  • Valverde, Marta
  • García-García, Judith
  • Nacht, Ana Silvina
  • Castillo, David
  • Dily, François Le
  • Neguembor, Maria Victoria
  • Malatesta, Marco
  • Bonnin, Sarah
  • Marti-Renom, Marc A.
  • Beato, Miguel
  • Vicent, Guillermo P.
The cancer epigenome has been studied in cells cultured in two-dimensional (2D) monolayers, but recent studies highlight the impact of the extracellular matrix and the three-dimensional (3D) environment on multiple cellular functions. Here, we report the physical, biochemical, and genomic differences between T47D breast cancer cells cultured in 2D and as 3D spheroids. Cells within 3D spheroids exhibit a rounder nucleus with less accessible, more compacted chromatin, as well as altered expression of ~2000 genes, the majority of which become repressed. Hi-C analysis reveals that cells in 3D are enriched for regions belonging to the B compartment, have decreased chromatin-bound CTCF and increased fusion of topologically associating domains (TADs). Upregulation of the Hippo pathway in 3D spheroids results in the activation of the LATS1 kinase, which promotes phosphorylation and displacement of CTCF from DNA, thereby likely causing the observed TAD fusions. 3D cells show higher chromatin binding of progesterone receptor (PR), leading to an increase in the number of hormone-regulated genes. This effect is in part mediated by LATS1 activation, which favors cytoplasmic retention of YAP and CTCF removal., The experimental work was supported by grants from the Departament d’Innovació Universitat i Empresa (DIUiE), the Spanish Ministry of Economy and Competitiveness (SAF2016-75006-P, PID2019-105173RB-I00, and PID2022-137045OB-I00) and Consejo Superior de Investigaciones Científicas (Ref# 201820I131), ‘Centro de Excelencia Severo Ochoa 2013-2017’, SEV-2012-2018 and ERC Synergy Grant “4DGenome” nr: 609989. MAM-R acknowledges support by the Spanish Ministerio de Ciencia e Innovación (PID2020-115696RB-I00). This work has benefited from the equipment and framework of the COMP-HUB and COMP-R Initiatives, funded by the ‘Departments of Excellence’ program of the Italian Ministry for University and Research (MIUR, 2018-2022 and MUR, 2023-2027) and from the HPC (High-Performance Computing) facility of the University of Parma, Italy., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

MyoD induces ARTD1 and nucleoplasmic poly-ADP-ribosylation during fibroblast to myoblast transdifferentiation

  • Bisceglie, Lavinia
  • Hopp, Ann-Katrin
  • Gunasekera, Kapila
  • Wright, Roni
  • Le Dily, François
  • Vidal, Enrique
  • Dall'Agnese, Alessandra
  • Caputo, Luca
  • Nicoletti, Chiara
  • Puri, Pier Lorenzo
  • Beato, Miguel
  • Hottiger, Michael O.
We thank Deena M. Leslie Pedrioli and Tobias Suter (University of Zurich) for providing editorial assistance. We thank the Center for Microscopy and Image Analysis (ZMB) and the Functional Genomics Center of the University of Zurich (FGCZ) for services and assistance. We especially thank Catharine Aquino from the FGCZ for helpful suggestions and discussions as well as technical support. PLP lab support from NIH/NIGMS (R01 GM134712-01), entitled ‘‘MYOD Regulation of 3D Chromatin Structure’’. Research in Beato’s lab is supported by funds from the European Research Council under the European Union’s Seventh Framework Program (FP7/2007-2013)/ERC Synergy grant agreement 609989 (4DGenome), from the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013-2017’ and Plan Nacional (SAF2016-75006-P), as well as support of the CERCA Program/Generalitat de Catalunya. L.B was supported by the Forschungskredit 2019 of the University of Zurich and K.G by a grant of the Oncosuisse (Nr. KFS-3740-08-2015-R). ADP-ribosylation research in the laboratory of MOH is funded by the Kanton of Zurich and the Swiss National Science Foundation, Switzerland (grant 31003A_176177)., While protein ADP-ribosylation was reported to regulate differentiation and dedifferentiation, it has so far not been studied during transdifferentiation. Here, we found that MyoD-induced transdifferentiation of fibroblasts to myoblasts promotes the expression of the ADP-ribosyltransferase ARTD1. Comprehensive analysis of the genome architecture by Hi-C and RNA-seq analysis during transdifferentiation indicated that ARTD1 locally contributed to A/B compartmentalization and coregulated a subset of MyoD target genes that were however not sufficient to alter transdifferentiation. Surprisingly, the expression of ARTD1 was accompanied by the continuous synthesis of nuclear ADP ribosylation that was neither dependent on the cell cycle nor induced by DNA damage. Conversely to the H2O2-induced ADP-ribosylation, the MyoD-dependent ADP-ribosylation was not associated to chromatin but rather localized to the nucleoplasm. Together, these data describe a MyoD-induced nucleoplasmic ADP-ribosylation that is observed particularly during transdifferentiation and thus potentially expands the plethora of cellular processes associated with ADP-ribosylation., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Hormone-control regions mediate steroid receptor-dependent genome organization

  • Le Dily, François
  • Vidal, Enrique
  • Cuartero, Yasmina
  • Quilez Oliete, Javier
  • Nacht, A. Silvina
  • Vicent, Guillermo P.
  • Carbonell-Caballero, Jose
  • Sharma, Priyanka
  • Villanueva Cañas, José Luis, 1984-
  • Ferrari, Roberto
  • De Llobet, Lara Isabel
  • Verde, Gaetano
  • Wright, Roni H.G.
  • Beato, Miguel
In breast cancer cells, some topologically associating domains (TADs) behave as hormonal gene regulation units, within which gene transcription is coordinately regulated in response to steroid hormones. Here we further describe that responsive TADs contain 20- to 100-kb-long clusters of intermingled estrogen receptor (ESR1) and progesterone receptor (PGR) binding sites, hereafter called hormone-control regions (HCRs). In T47D cells, we identified more than 200 HCRs, which are frequently bound by unliganded ESR1 and PGR. These HCRs establish steady long-distance inter-TAD interactions between them and organize characteristic looping structures with promoters in their TADs even in the absence of hormones in ESR1+-PGR+ cells. This organization is dependent on the expression of the receptors and is further dynamically modulated in response to steroid hormones. HCRs function as platforms that integrate different signals, resulting in some cases in opposite transcriptional responses to estrogens or progestins. Altogether, these results suggest that steroid hormone receptors act not only as hormone-regulated sequence-specific transcription factors but also as local and global genome organizers., We received funding from the European Research Council under the European Union's Seventh Framework Program (FP7/2007–2013)/ERC Synergy grant agreement 609989 (4DGenome). The content of this manuscript reflects only the author's views and the Union is not liable for any use that may be made of the information contained therein. We acknowledge support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013–2017’ and Plan Nacional (SAF2016-75006-P), as well as support of the CERCA Programme/Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

LATS1 controls CTCF chromatin occupancy and hormonal response of 3D-grown breast cancer cells

  • Ramírez Cuéllar, Angélica Julieta
  • Ferrari, Roberto
  • Sanz, Rosario T.
  • Valverde Santiago, Marta
  • García García, Judith
  • Nacht, A. Silvina
  • Castillo, David
  • Le Dily, François
  • Neguembor, Maria Victoria
  • Malatesta, Marco
  • Bonnin, Sarah
  • Martí Renom, Marc A.
  • Beato, Miguel
  • Vicent, Guillermo P.
The cancer epigenome has been studied in cells cultured in two-dimensional (2D) monolayers, but recent studies highlight the impact of the extracellular matrix and the three-dimensional (3D) environment on multiple cellular functions. Here, we report the physical, biochemical, and genomic differences between T47D breast cancer cells cultured in 2D and as 3D spheroids. Cells within 3D spheroids exhibit a rounder nucleus with less accessible, more compacted chromatin, as well as altered expression of ~2000 genes, the majority of which become repressed. Hi-C analysis reveals that cells in 3D are enriched for regions belonging to the B compartment, have decreased chromatin-bound CTCF and increased fusion of topologically associating domains (TADs). Upregulation of the Hippo pathway in 3D spheroids results in the activation of the LATS1 kinase, which promotes phosphorylation and displacement of CTCF from DNA, thereby likely causing the observed TAD fusions. 3D cells show higher chromatin binding of progesterone receptor (PR), leading to an increase in the number of hormone-regulated genes. This effect is in part mediated by LATS1 activation, which favors cytoplasmic retention of YAP and CTCF removal., The authors would like to thank Jianrong Lu (University of Florida College of Medicine, USA) for generously sharing the CTCF constructs. Additionally, we also would like to thank Dr. Julia Ponomarenko (Bioinformatics Unit, CRG) for their valuable advice, technical assistance and involvement in processing the RNA-seq, ChIP-seq, and ATAC-seq data. The experimental work was supported by grants from the Departament d’Innovació Universitat i Empresa (DIUiE), the Spanish Ministry of Economy and Competitiveness (SAF2016-75006-P, PID2019-105173RB-I00, and PID2022-137045OB-I00) and Consejo Superior de Investigaciones Científicas (Ref# 201820I131), ‘Centro de Excelencia Severo Ochoa 2013-2017’, SEV-2012-2018 and ERC Synergy Grant “4DGenome” nr: 609989. MAM-R acknowledges support by the Spanish Ministerio de Ciencia e Innovación (PID2020-115696RB-I00). This work has benefited from the equipment and framework of the COMP-HUB and COMP-R Initiatives, funded by the ‘Departments of Excellence’ program of the Italian Ministry for University and Research (MIUR, 2018-2022 and MUR, 2023-2027) and from the HPC (High-Performance Computing) facility of the University of Parma, Italy.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells

  • Ogara, Maria F.
  • Rodríguez Seguí, Santiago A.
  • Marini, Melisa
  • Silvina Nacht, Ana
  • Stortz, Martin
  • Levi, Valeria
  • Presman, Diego M.
  • Vicent, Guillermo P.
  • Pecci, Adali
The glucocorticoid and progesterone receptors (GR and PR) are closely related members of the steroid receptor family. Despite sharing similar structural and functional characteristics; the cognate hormones display very distinct physiological responses. In mammary epithelial cells, PR activation is associated with the incidence and progression of breast cancer, whereas the GR is related to growth suppression and differentiation. Despite their pharmacological relevance, only a few studies have compared GR and PR activities in the same system. Using a PR+/GR+ breast cancer cell line, here we report that either glucocorticoid-free or dexamethasone (DEX)-activated GR inhibits progestin-dependent gene expression associated to epithelial-mesenchymal-transition and cell proliferation. When both receptors are activated with their cognate hormones, PR and GR can form part of the same complex according to co-immunoprecipitation, quantitative microscopy and sequential ChIP experiments. Moreover, genome-wide studies in cells treated with either DEX or R5020, revealed the presence of several regions co-bound by both receptors. Surprisingly, GR also binds novel genomic sites in cells treated with R5020 alone. This progestin-induced GR binding was enriched in REL DNA motifs and located close to genes coding for chromatin remodelers. Understanding GR behavior in the context of progestin-dependent breast cancer could provide new targets for tumor therapy., Spanish Ministry of Economy and Competitiveness, Spain [SAF2016-75006P]; CONICET [PIP112-200801-00859]; Agencia Nacional de Programación Científica y Tecnológica [Préstamo BID-PICT2014-0630]; University of Buenos Aires, Argentina [20820180100745BA]. CONICET-Argentina (M.F.O., S.A.R.S., V.L, D.M.P, A.P.); Spanish National Research Council (CSIC), Spain (to G.P.V.); IUBMB Short-term Scholarship (to M.F.O, M.S.M.); EMBO Short-term Scholarship (to M.F.O.).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

MyoD induces ARTD1 and nucleoplasmic poly-ADP-ribosylation during fibroblast to myoblast transdifferentiation

  • Bisceglie, Lavinia
  • Hopp, Ann-Katrin
  • Gunasekera, Kapila
  • Wright, Roni H.G.
  • Le Dily, François
  • Vidal, Enrique
  • Dall'Agnese, Alessandra
  • Caputo, Luca
  • Nicoletti, Chiara
  • Puri, Pier Lorenzo
  • Beato, Miguel
  • Hottiger, Michael O.
While protein ADP-ribosylation was reported to regulate differentiation and dedifferentiation, it has so far not been studied during transdifferentiation. Here, we found that MyoD-induced transdifferentiation of fibroblasts to myoblasts promotes the expression of the ADP-ribosyltransferase ARTD1. Comprehensive analysis of the genome architecture by Hi-C and RNA-seq analysis during transdifferentiation indicated that ARTD1 locally contributed to A/B compartmentalization and coregulated a subset of MyoD target genes that were however not sufficient to alter transdifferentiation. Surprisingly, the expression of ARTD1 was accompanied by the continuous synthesis of nuclear ADP ribosylation that was neither dependent on the cell cycle nor induced by DNA damage. Conversely to the H2O2-induced ADP-ribosylation, the MyoD-dependent ADP-ribosylation was not associated to chromatin but rather localized to the nucleoplasm. Together, these data describe a MyoD-induced nucleoplasmic ADP-ribosylation that is observed particularly during transdifferentiation and thus potentially expands the plethora of cellular processes associated with ADP-ribosylation., Research in Beato's lab is supported by funds from the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC Synergy grant agreement 609989 (4DGenome), from the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013-2017’ and Plan Nacional (SAF2016-75006-P), as well as support of the CERCA Program/Generalitat de Catalunya. L.B was supported by the Forschungskredit 2019 of the University of Zurich and K.G by a grant of the Oncosuisse (Nr. KFS-3740-08-2015-R). ADP-ribosylation research in the laboratory of MOH is funded by the Kanton of Zurich and the Swiss National Science Foundation, Switzerland (grant 31003A_176177).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells

  • Nacht, A. Silvina
  • Ferrari, Roberto
  • Zaurín Quer, Roser
  • Scabia, Valentina
  • Carbonell-Caballero, Jose
  • Le Dily, François
  • Quilez Oliete, Javier
  • Leopoldi, Alexandra
  • Brisken, Cathrin
  • Beato, Miguel
  • Vicent, Guillermo P.
Steroid hormones are key gene regulators in breast cancer cells. While estrogens stimulate cell proliferation, progestins activate a single cell cycle followed by proliferation arrest. Here, we use biochemical and genome-wide approaches to show that progestins achieve this effect via a functional crosstalk with C/EBPα. Using ChIP-seq, we identify around 1,000 sites where C/EBPα binding precedes and helps binding of progesterone receptor (PR) in response to hormone. These regions exhibit epigenetic marks of active enhancers, and C/EBPα maintains an open chromatin conformation that facilitates loading of ligand-activated PR. Prior to hormone exposure, C/EBPα favors promoter-enhancer contacts that assure hormonal regulation of key genes involved in cell proliferation by facilitating binding of RAD21, YY1, and the Mediator complex. Knockdown of C/EBPα disrupts enhancer-promoter contacts and decreases the presence of these architectural proteins, highlighting its key role in 3D chromatin looping. Thus, C/EBPα fulfills a previously unknown function as a potential growth modulator in hormone-dependent breast cancer., The experimental work was supported by grants from the Departament d’Innovació, Universitat i Empresa (DIUiE), and the Spanish Ministry of Economy and Competitiveness (SAF2016-75006P), “Centro de Excelencia Severo Ochoa 2013-2017”, SEV-2012-0208 and ERC Synergy Grant “4DGenome” nr: 609989
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations

  • Zaurín Quer, Roser
  • Ferrari, Roberto
  • Nacht, A. Silvina
  • Carbonell-Caballero, Jose
  • Le Dily, François
  • Font Mateu, Jofre, 1977-
  • De Llobet, Lara Isabel
  • Vidal Ocabo, Enrique
  • Lioutas, Antonio, 1980-
  • Beato, Miguel
  • Vincent, Guillermo P.
Here, we report that in T47D breast cancer cells 50 pM progestin is sufficient to activate cell cycle entry and the progesterone gene expression program. At this concentration, equivalent to the progesterone blood levels found around the menopause, progesterone receptor (PR) binds only to 2800 genomic sites, which are accessible to ATAC cleavage prior to hormone exposure. These highly accessible sites (HAs) are surrounded by well-organized nucleosomes and exhibit breast enhancer features, including estrogen receptor alpha (ERα), higher FOXA1 and BRD4 (bromodomain containing 4) occupancy. Although HAs are enriched in RAD21 and CTCF, PR binding is the driving force for the most robust interactions with hormone-regulated genes. HAs show higher frequency of 3D contacts among themselves than with other PR binding sites, indicating colocalization in similar compartments. Gene regulation via HAs is independent of classical coregulators and ATP-activated remodelers, relying mainly on MAP kinase activation that enables PR nuclear engagement. HAs are also preferentially occupied by PR and ERα in breast cancer xenografts derived from MCF-7 cells as well as from patients, indicating their potential usefulness as targets for therapeutic intervention., Funding: Ministerio de Ciencia e Innovación [PID2019-105173RB-I00 and PID2019-110384GB-C21]; Spanish Ministry of Economy and Competitiveness [SAF2016-75006-P and G62426937]; Consejo Superior de Investigaciones Científicas [201820I131]; Centro de Excelencia Severo Ochoa [SEV-2012-2018]; European Research Council [609989]. Funding for open access charge: Ministerio de Ciencia e Innovación
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Signaling by steroid hormones in the 3D nuclear space

  • Le Dily, François
  • Beato, Miguel
Initial studies showed that ligand-activated hormone receptors act by binding to the proximal promoters of individual target genes. Genome-wide studies have now revealed that regulation of transcription by steroid hormones mainly depends on binding of the receptors to distal regulatory elements. Those distal elements, either enhancers or silencers, act on the regulation of target genes by chromatin looping to the gene promoters. In the nucleus, this level of chromatin folding is integrated within dynamic higher orders of genome structures, which are organized in a non-random fashion. Terminally differentiated cells exhibit a tissue-specific three-dimensional (3D) organization of the genome that favors or restrains the activity of transcription factors and modulates the function of steroid hormone receptors, which are transiently activated upon hormone exposure. Conversely, integration of the hormones signal may require modifications of the 3D organization to allow appropriate transcriptional outcomes. In this review, we summarize the main levels of organization of the genome, review how they can modulate the response to steroids in a cell specific manner and discuss the role of receptors in shaping and rewiring the structure in response to hormone. Taking into account the dynamics of 3D genome organization will contribute to a better understanding of the pleiotropic effects of steroid hormones in normal and cancer cells., We thank all members of the Chromatin and Gene Expression group (CRG, Barcelona) and the members of the 4DGenome project (CRG and CNAG-CRG, Barcelona) for helpful discussions. Research in the Beato’s laboratory receives funding from the European Research Council under the European Union’s Seventh Framework Programme (FP7/2007-2013)/ERC Synergy grant agreement 609989 (4DGenome). The content of this manuscript reflects only the author’s views and the Union is not liable for any use that may be made of the information contained therein. We also acknowledge support of the Spanish Ministry of Economy and Competitiveness, “Centro de Excelencia Severo Ochoa 2013-2017” and Plan Nacional (SAF2016-75006-P), as well as support of the CERCA Programme/Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Hormone-control regions mediate steroid receptor–dependent genome organization

  • Le Dily, François
  • Vidal, Enrique
  • Cuartero, Yasmina
  • Quilez Oliete, Javier
  • Nacht, A. Silvina
  • Vicent, Guillermo P.
  • Carbonell-Caballero, José
  • Sharma, Priyanka
  • Villanueva-Cañas, José Luis
  • Ferrari, Roberto
  • De Llobet, Lara Isabel
  • Verde, Gaetano
  • Wright, Roni
  • Beato, Miguel
We thank the CRG Ultra-sequencing Facility for technical support and all members of the Chromatin and Gene Expression group for helpful discussions. We acknowledge the members of the 4DGenome project (CRG and CNAG-CRG, Barcelona), notably Thomas Graf, Marc A. Marti-Renom, and Guillaume Filion, as well as Ramon Amat (UPF, Barcelona) for their helpful comments on the manuscript. We thank Dr. Cheng-Ming Chiang (UT Southwestern Medical Center) for kindly providing antibody against BRD4. We received funding from the European Research Council under the European Union’s Seventh Framework Program (FP7/2007–2013)/ERC Synergy grant agreement 609989 (4DGenome). The content of this manuscript reflects only the author’s views and the Union is not liable for any use that may be made of the information contained therein. We acknowledge support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013–2017’ and Plan Nacional (SAF2016-75006-P), as well as support of the CERCA Programme/Generalitat de Catalunya., In breast cancer cells, some topologically associating domains (TADs) behave as hormonal gene regulation units, within which gene transcription is coordinately regulated in response to steroid hormones. Here we further describe that responsive TADs contain 20- to 100-kb-long clusters of intermingled estrogen receptor (ESR1) and progesterone receptor (PGR) binding sites, hereafter called hormone-control regions (HCRs). In T47D cells, we identified more than 200 HCRs, which are frequently bound by unliganded ESR1 and PGR. These HCRs establish steady long-distance inter-TAD interactions between them and organize characteristic looping structures with promoters in their TADs even in the absence of hormones in ESR1+-PGR+ cells. This organization is dependent on the expression of the receptors and is further dynamically modulated in response to steroid hormones. HCRs function as platforms that integrate different signals, resulting in some cases in opposite transcriptional responses to estrogens or progestins. Altogether, these results suggest that steroid hormone receptors act not only as hormone-regulated sequence-specific transcription factors but also as local and global genome organizers., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The embryonic linker histone dBigH1 alters the functional state of active chromatin

  • Climent-Cantó, Paula
  • Carbonell, Albert
  • Tatarski, Milos
  • Reina García, Óscar, 1976-
  • Bujosa, Paula
  • Font Mateu, Jofre, 1977-
  • Bernués, Jordi
  • Beato, Miguel
  • Azorín Marín, Fernando
Linker histones H1 are principal chromatin components, whose contribution to the epigenetic regulation of chromatin structure and function is not fully understood. In metazoa, specific linker histones are expressed in the germline, with female-specific H1s being normally retained in the early-embryo. Embryonic H1s are present while the zygotic genome is transcriptionally silent and they are replaced by somatic variants upon activation, suggesting a contribution to transcriptional silencing. Here we directly address this question by ectopically expressing dBigH1 in Drosophila S2 cells, which lack dBigH1. We show that dBigH1 binds across chromatin, replaces somatic dH1 and reduces nucleosome repeat length (NRL). Concomitantly, dBigH1 expression down-regulates gene expression by impairing RNApol II binding and histone acetylation. These effects depend on the acidic N-terminal ED-domain of dBigH1 since a truncated form lacking this domain binds across chromatin and replaces dH1 like full-length dBigH1, but it does not affect NRL either transcription. In vitro reconstitution experiments using Drosophila preblastodermic embryo extracts corroborate these results. Altogether these results suggest that the negatively charged N-terminal tail of dBigH1 alters the functional state of active chromatin compromising transcription., Funding: MINECO [BFU2015-65082-P, PGC2018-094538-B-100]; Generalitat de Catalunya [SGR2014-204, SGR2017-475]; European Community FEDER program (to F.A.); MEC ‘Centro de Excelencia Severo Ochoa 2013–2017’ [SEV-2012-0208]; MINECO [SAF2016-75006-P to M.B.]; ‘Centre de Referència en Biotecnologia’ of the Generalitat de Catalunya. Funding for open access charge: MINECO